Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

169.78 +1.64 (+0.98%)
Streaming Delayed Price Updated: 10:17 AM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 357,627
Open 167.52
Bid (Size) 169.72 (2)
Ask (Size) 169.84 (2)
Prev. Close 168.14
Today's Range 167.35 - 169.90
52wk Range 132.70 - 182.89
Shares Outstanding N/A
Dividend Yield 3.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
Drug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year. In January 2024 
Via MarketBeat

Performance

YTD
+6.23%
+6.23%
1 Month
-0.40%
-0.40%
3 Month
+0.44%
+0.44%
6 Month
+2.97%
+2.97%
1 Year
+25.23%
+25.23%

More News

Read More
The 7 Best Warren Buffett Stocks to Buy in July 2024
Via InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
Via Benzinga
A Closer Look at AbbVie's Options Market Dynamics
Via Benzinga
A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts
Via Benzinga
The Smartest Dividend Stocks to Buy With $250 Right Now
Via The Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Via Benzinga
Topics ETFs
MarketBeat Week in Review – 7/1 - 7/5
Via MarketBeat
Topics Economy
Exposures Interest Rates
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
New Golden Investment: Universal Health Realty Income Trust
Via Talk Markets
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Via InvestorPlace
3 Retirement All-Stars for Steady Growth and Income
Via InvestorPlace
Topics Retirement
Exposures Pension
Cash Flow Alert: 3 Stocks That Just Raised Their Dividends
Via InvestorPlace
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Via The Motley Fool
3 Magnificent Stocks Retirees Can Buy and Hold Forever
Via The Motley Fool
Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
7 Dividend Kings to Buy With Your Roth IRA Money in 2024
Via InvestorPlace
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
Via Benzinga
Exposures Product Safety
Can AbbVie Stock Keep Outpacing the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.